文献速递技术与安全头颈PETCT

FAPI PET/CT在原发灶不明癌症(CUP)中的作用:一项系统综述

Role of FAPI PET/CT in cancer of unknown primary (CUP): A systematic review.
PubMed 文献 · Eur J Radiol · 2025-07-23

本系统综述分析FAPI PET/CT诊断原发灶不明癌症(CUP)的价值,检索到4项符合纳入标准的研究,其中2项针对头颈部CUP、2项针对全身CUP。头颈部组FAPI PET/CT的肿瘤-本底比(TBR)及原发灶检出率显著高于[18F]FDG PET/CT;全身组FAPI PET的SUVmax和TBR更高,一项研究报告原发灶识别率为68%(30/44)。结果提示FAPI PET/CT在检测原发灶和转移灶方面敏感度更优,尤其在[18F]FDG PET/CT效果欠佳的病例中。

要点

  • 头颈部CUP中FAPI PET/CT的TBR及原发灶检出率显著高于[18F]FDG PET/CT。
  • 全身CUP中FAPI PET的SUVmax和TBR高于[18F]FDG PET。
  • 一项研究报告FAPI PET/CT原发灶识别率为68%(30/44)。

核心结论

  • FAPI PET/CT在检测CUP原发肿瘤和转移灶方面提供更优的敏感度,尤其在[18F]FDG PET/CT效果欠佳的病例中,可能提高诊断准确性。

研究设计与样本

  • 系统综述,纳入4项研究,其中2项针对头颈部CUP、2项针对全身CUP,对比FAPI PET/CT与[18F]FDG PET/CT。

关键影像表现/征象

  • 头颈部CUP组FAPI PET/CT的肿瘤-本底比(TBR)显著高于[18F]FDG PET/CT。
  • 全身CUP组FAPI PET的SUVmax和TBR高于[18F]FDG PET。

诊断标准与关键数值

  • 头颈部CUP组FAPI PET/CT原发灶检出率优于[18F]FDG PET/CT。
  • 全身CUP组一项研究报告FAPI PET/CT原发灶识别率为68%(30/44)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This systematic review analyzes the value of FAPI PET/CT in diagnosing cancer of unknown primary (CUP). CUP is a metastatic malignant disease in which the site of origin cannot be determined. It accounts for 3-5 % of all malignant neoplasms and has a poor prognosis with a median survival of 6 to 9 months. Currently, CT, MRI and [18F]FDG PET/CT are the preferred imaging modalities. FAPI PET/CT has been shown to outperform [18F]FDG in a wide range of oncological settings and this promising radioligand could benefit the management of CUP by improving the detection rate of the primary site. A systematic search revealed four studies that met our inclusion criteria. Two studies focused on CUP in the head and neck region and two on general CUP. In the head and neck group FAPI PET/CT has a significantly higher tumor-to-background ratio (TBR) and a better detection rate of the primary site compared to [18F]FDG PET/CT. Also in the general group, FAPI PET showed a higher SUVmax and TBR in CUP patients compared to [18F]FDG PET and one study reported identification of the primary site in 68% (30/44). These results suggest that FAPI PET/CT provides superior sensitivity in detecting both primary tumors and metastatic lesions, particularly in cases in which [18F]FDG PET/CT is less effective. This highlights the potential of FAPI PET/CT to enhance diagnostic accuracy in oncology, especially for patients with challenging cases.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Maes J, Cleeren F, Goffin K, et al. Role of FAPI PET/CT in cancer of unknown primary (CUP): A systematic review. Eur J Radiol. 2025. PMID: 40714678. doi:10.1016/j.ejrad.2025.112330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。